Peter Sand to Risk Assessment
This is a "connection" page, showing publications Peter Sand has written about Risk Assessment.
Connection Strength
0.294
-
Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J Urol. 2013 Sep; 190(3):958-64.
Score: 0.065
-
Predictors of persistent detrusor overactivity after transvaginal sling procedures. Am J Obstet Gynecol. 2008 Dec; 199(6):696.e1-7.
Score: 0.048
-
Site-specific rectocele repair compared with standard posterior colporrhaphy. Obstet Gynecol. 2005 Feb; 105(2):314-8.
Score: 0.037
-
A comparison of extended-release oxybutynin and tolterodine for treatment of overactive bladder in women. Int Urogynecol J Pelvic Floor Dysfunct. 2004 Jul-Aug; 15(4):243-8.
Score: 0.036
-
A randomized controlled trial comparing a modified Burch procedure and a suburethral sling: long-term follow-up. Int Urogynecol J Pelvic Floor Dysfunct. 2003 Oct; 14(4):229-33; discussion 233.
Score: 0.034
-
Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence. J Urol. 2019 05; 201(5):967-972.
Score: 0.025
-
OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol. 2013 Jun; 189(6):2186-93.
Score: 0.016
-
Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome. J Urol. 2007 Dec; 178(6):2488-94.
Score: 0.011
-
Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence. Urology. 2007 May; 69(5):876-80.
Score: 0.011
-
Effect of parity on sexual function: an identical twin study. Obstet Gynecol. 2006 Apr; 107(4):765-70.
Score: 0.010